[Therapeutic effect of bronchospasmin in bronchial asthma patients].
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009921:Metaproterenol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D012138:Respiratory Therapy; D013607:Tablets; D013806:Theophylline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D001993:Bronchodilator Agents; D004338:Drug Combinations; D013607:Tablets; C014792:reproterol; D009921:Metaproterenol; D013806:Theophylline
Prouchvane vŭrkhu lechebniia efekt na bronchospasmin pri bolni s bronkhialna astma.